Edwards Lifesciences Revenue Growth Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 139.52  0.45  0.32%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Revenue Growth of Edwards Lifesciences Corporation with missing and latest data points interpolated. Measures the growth in Revenues over the specified period.
Revenue Growth  10 Years Trend  
Slightly volatile
 Revenue Growth 

Edwards Lifesciences Revenue Growth Over Time

2016-12-31  0.073529 
2017-12-31  0.073529 
2018-12-31  0.086504 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  0.11
Geometric Mean  0.097871
Coefficient Of Variation  45.15
Mean Deviation  0.038795
Median  0.086504
Standard Deviation  0.04802
Sample Variance  0.002306
Range  0.17
R Value (0.42)
Mean Square Error  0.002078
R Squared  0.17
Significance  0.16
Slope (0.005141)
Total Sum of Squares  0.027672

Currently Trending

Sold over 70 shares of
a day ago ago
Traded for 37.94
Purchased over 40 shares of
a day ago ago
Traded for 61.5945
Sold over 200 shares of
a day ago ago
Traded for 11.15